Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery

Am J Physiol Gastrointest Liver Physiol. 2020 Apr 1;318(4):G661-G672. doi: 10.1152/ajpgi.00265.2019. Epub 2020 Feb 18.

Abstract

Postprandial gut hormone responses change after Roux-en-Y gastric bypass (RYGB), and we investigated the impact of glucose, protein, and fat (with and without pancreas lipase inhibition) on plasma responses of gut and pancreas hormones, bile acids, and fibroblast growth factor 21 (FGF-21) after RYGB and in nonoperated control subjects. In a randomized, crossover study 10 RYGB operated and 8 healthy weight-matched control subjects were administered 4 different 4-h isocaloric (200 kcal) liquid meal tests containing >90 energy (E)% of either glucose, protein (whey protein), or fat (butter with and without orlistat). The primary outcome was glucagon-like peptide-1 (GLP-1) secretion (area under the curve above baseline). Secondary outcomes included responses of peptide YY (PYY), glucose-dependent insulinotropic polypeptide (GIP), cholecystokinin (CCK), glicentin, neurotensin, ghrelin, insulin, glucagon, bile acids, and FGF-21. In the RYGB group the responses of GLP-1, GIP, glicentin, FGF-21, and C-peptide were increased after glucose compared with the other meals. The neurotensin and bile acids responses were greater after fat, while the glucagon and CCK responses were greater after protein ingestion. Furthermore, compared with control subjects, RYGB subjects had greater responses of total PYY after glucose, glucagon after glucose and fat, glicentin after glucose and protein, and GLP-1 and neurotensin after all meals, while GIP and CCK responses were lower after fat. Ghrelin responses did not differ between meals or between groups. Orlistat reduced all hormone responses to fat ingestion, except for ghrelin in the RYGB group. In conclusion, after RYGB glucose is a more potent stimulator of most gut hormones, especially for the marked increased secretion of GLP-1 compared with fat and protein.NEW & NOTEWORTHY We investigated the impact of glucose, protein, and fat meals on intestinal and pancreatic hormones, bile acid, and fibroblast growth factor 21 (FGF-21) secretion in gastric bypass-operated patients compared with matched nonoperated individuals. The fat meal was administered with and without a pancreas lipase inhibitor. We found that the impact of the different meals on gut hormones, bile, and FGF 21 secretion differ and was different from the responses observed in nonoperated control subjects.

Keywords: FGF21; RYGB; bile acids; carbohydrate; gut hormones; protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaminophen / administration & dosage
  • Acetaminophen / blood
  • Acetaminophen / pharmacokinetics
  • Adolescent
  • Adult
  • Analgesics, Non-Narcotic / administration & dosage
  • Analgesics, Non-Narcotic / blood
  • Analgesics, Non-Narcotic / pharmacokinetics
  • Bile Acids and Salts / metabolism*
  • Blood Glucose
  • Cholecystokinin / metabolism
  • Dietary Fats
  • Dietary Proteins / administration & dosage
  • Female
  • Fibroblast Growth Factors / metabolism*
  • Gastric Bypass*
  • Gastric Inhibitory Polypeptide / metabolism
  • Gastrointestinal Tract / metabolism*
  • Ghrelin / metabolism
  • Glicentin / metabolism
  • Glucagon / metabolism
  • Glucose / administration & dosage*
  • Glucose / metabolism
  • Humans
  • Male
  • Middle Aged
  • Neurotensin / metabolism
  • Pancreas / metabolism*
  • Young Adult

Substances

  • Analgesics, Non-Narcotic
  • Bile Acids and Salts
  • Blood Glucose
  • Dietary Fats
  • Dietary Proteins
  • Ghrelin
  • fibroblast growth factor 21
  • Acetaminophen
  • Neurotensin
  • Gastric Inhibitory Polypeptide
  • Fibroblast Growth Factors
  • Glicentin
  • Glucagon
  • Cholecystokinin
  • Glucose